Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1,935 GBX | +0.57% | +6.38% | +8.16% |
Apr. 26 | HIKMA PHARMACEUTICALS : Hikma’s Q1 progress appreciated by the markets | |
Apr. 25 | Hikma Pharmaceuticals plc Approves Final Dividend, Payable on 3 May 2024 | CI |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+8.16% | 5.35B | |
+33.28% | 704B | |
+28.59% | 577B | |
-3.85% | 348B | |
+18.33% | 327B | |
+4.98% | 288B | |
+14.81% | 234B | |
+4.93% | 198B | |
-9.78% | 194B | |
-4.12% | 147B |
- Stock Market
- Equities
- HIK Stock
- News Hikma Pharmaceuticals PLC
- Transcript : Hikma Pharmaceuticals PLC, 2023 Earnings Call, Feb 22, 2024